172 Thomas Johnson Drive, Ste 202 Frederick, MD 21702, United States

301-698-8300

301-698-8300

  • Home
  • Doctors
  • EEG
  • EMG
  • Botox
  • Migraine Handouts
  • Online Forms
  • Downloads
  • Contact Us
  • More
    • Home
    • Doctors
    • EEG
    • EMG
    • Botox
    • Migraine Handouts
    • Online Forms
    • Downloads
    • Contact Us
  • Home
  • Doctors
  • EEG
  • EMG
  • Botox
  • Migraine Handouts
  • Online Forms
  • Downloads
  • Contact Us

Mid-Maryland Neurology, PA

Mid-Maryland Neurology, PAMid-Maryland Neurology, PAMid-Maryland Neurology, PA

Richard T. Leschek DO Neurologist

Richard T. Leschek DO NeurologistRichard T. Leschek DO Neurologist

Botulinum Toxin

Botulinum Toxin Injections

Botulinum toxin was introduced as a therapeutic medication in the late 1980s. It revolutionized the treatment of dystonia by offering a localized method to relieve overactive muscle contractions. Botulinum toxin is injected directly into specific muscles where it acts to relax those muscles and reduce excessive muscle contractions.
 

Botulinum toxin is a biological product derived from the Clostridium botulinum bacterium. It binds to the nerves that lead to the muscle and prevents the release of acetylcholine which is a neurotransmitter that activates muscle contractions. When that messenger is blocked, muscle spasms are significantly reduced or eliminated.


Botulinum toxin is not a cure. Conditions with overactive muscles such as cervical dystonia and blepharospasm often require long term treatment. The benefits of each treatment may begin within 3 days to 2 weeks depending on the condition. The effects will usually last about 3 months. Treatments can continue as long as the condition continues to respond and you don’t experience an allergic reaction or any significant side effects.


Side Effects

The most frequent adverse reactions reported when using botulinum toxin to treat cervical dystonia include dysphagia (trouble swallowing 19%), cold or flu (12%), neck pain (11%) and headache (11%). When treating blepharospasm the most commonly reported adverse reactions were ptosis (droopy eyelids, 21%), inflammation of the cornea (6%) and dry eyes (6%).


Copyright © 2020 Mid Maryland Neurology, PA - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept